Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 39,614 |
|
|||||
| News | - | ||||||
| Day High | 1.6799 | Low High |
|||||
| Day Low | 1.56 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Processa Pharmaceuticals Inc | PCSA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.02 | 1.25% | 1.62 | 17:01:45 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.58 | 1.56 | 1.6799 | 1.62 | 1.60 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 245 | 39,614 | $ 1.63 | $ 64,671 | - | 1.40 - 18.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:31:07 | 41 | $ 1.62 | USD |
Processa Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.06M | 1.23M | - | 0 | -11.12M | -9.03 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Processa Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PCSA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.53 | 1.7071 | 1.50 | 1.60 | 43,469 | 0.09 | 5.88% |
| 1 Month | 2.19 | 3.305 | 1.40 | 2.36 | 454,360 | -0.57 | -26.03% |
| 3 Months | 2.56 | 3.305 | 1.40 | 2.36 | 252,588 | -0.94 | -36.72% |
| 6 Months | 6.00 | 17.40 | 1.40 | 5.60 | 1,575,071 | -4.38 | -73.00% |
| 1 Year | 10.60 | 18.00 | 1.40 | 7.53 | 1,296,989 | -8.98 | -84.72% |
| 3 Years | 178.80 | 184.80 | 1.40 | 12.97 | 482,454 | -177.18 | -99.09% |
| 5 Years | 76.00 | 284.798 | 1.40 | 16.83 | 416,730 | -74.38 | -97.87% |
Processa Pharmaceuticals Description
| Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on the development of drug products that are intended to improve the survival and quality of life for patients who have an unmet medical need. The company's lead product, PCS499 is an oral tablet that is an analog of an active metabolite of an already approved drug. It focuses on fibrotic related diseases such as focal segmental glomerulosclerosis, idiopathic pulmonary fibrosis. Its pipeline products comprise PCS6422, PCS12852, and PCS100. |
